يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"Bachelez, Hervé"', وقت الاستعلام: 1.50s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial.

    المؤلفون: Bachelez, Hervé1 herve.bachelez@sls.aphp.fr, van de Kerkhof, Peter C. M.2, Strohal, Robert3, Kubanov, Alexey4, Valenzuela, Fernando5,6, Joo-Heung Lee7, Yakusevich, Vladimir8, Chimenti, Sergio9, Papacharalambous, Jocelyne10, Proulx, James10, Gupta, Pankaj10, Huaming Tan10, Tawadrous, Margaret10, Valdez, Hernan10, Wolk, Robert10

    المصدر: Lancet. 8/8/2015, Vol. 386 Issue 9993, p552-561. 10p. 2 Diagrams, 3 Charts, 1 Graph.

    مصطلحات موضوعية: ETANERCEPT, PLACEBOS, PSORIASIS, PSORIASIS treatment, DRUG dosage, PATIENTS, THERAPEUTICS


    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Interleukin 23 inhibitors for psoriasis: not just another number.

    المؤلفون: Bachelez, Hervé1 herve.bachelez@sls.aphp.fr

    المصدر: Lancet. 7/15/2017, Vol. 390 Issue 10091, p208-210. 3p.

    مصطلحات موضوعية: *RESEARCH, INTERLEUKIN-23, INTERLEUKINS, DRUG efficacy, PSORIASIS treatment, MEDICATION safety, THERAPEUTICS, COMPARATIVE studies, RESEARCH methodology, MEDICAL cooperation, PSORIASIS, EVALUATION research

    People: REICH, Kristian


    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Interleukin-17 inhibition: a route to psoriasis clearance?

    المؤلفون: Bachelez, Hervé1,2,3 herve.bachelez@sls.aphp.fr

    المصدر: Lancet. 8/8/2015, Vol. 386 Issue 9993, p510-512. 3p. 1 Color Photograph.

    مصطلحات موضوعية: INTERLEUKIN-17, PSORIASIS treatment, IMMUNOLOGIC diseases, PSORIATIC arthritis, ANKYLOSING spondylitis treatment, THERAPEUTICS


    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials.

    المؤلفون: Gordon, Kenneth B.1, Puig, Lluís2, Foley, Peter3, Mamitaro Ohtsuki4, Flack, Mary5, Ziqian Geng6, Yihua Gu6, Valdes, Joaquin M.6, Thompson, Elizabeth H. Z.7, Bachelez, Hervé8, Strober, Bruce9, Lebwohl, Mark9, Augustin, Matthias9, Blauvelt, Andrew9, Poulin, Yves9, Papp, Kim A.9, Sofen, Howard9, Ohtsuki, Mamitaro10 (AUTHOR), Geng, Ziqian11 (AUTHOR), Gu, Yihua11 (AUTHOR)

    المصدر: Lancet. 8/25/2018, Vol. 392 Issue 10148, p650-661. 12p. 4 Charts, 4 Graphs.

    مصطلحات موضوعية: *PSORIASIS treatment, *MONOCLONAL antibodies, *INTERLEUKIN-23, *CYTOKINES, *PLACEBOS, *THERAPEUTIC use of immunoglobulins, *SUBCUTANEOUS injections, *COMPARATIVE studies, *DERMATOLOGIC agents, *INTERLEUKINS, *RESEARCH methodology, *MEDICAL cooperation, *PSORIASIS, *RESEARCH, *STATISTICAL sampling, *TUMOR necrosis factors, *EVALUATION research, *RANDOMIZED controlled trials, *TREATMENT effectiveness, *BLIND experiment, *SEVERITY of illness index, *PHARMACODYNAMICS


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث